Stock DNA
Pharmaceuticals & Biotechnology
CNY 9,367 Million (Small Cap)
36.00
NA
0.13%
-0.41
6.95%
2.48
Revenue and Profits:
Net Sales:
403 Million
(Quarterly Results - Mar 2026)
Net Profit:
57 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
2.19%
0%
2.19%
6 Months
27.45%
0%
27.45%
1 Year
62.76%
0%
62.76%
2 Years
40.48%
0%
40.48%
3 Years
-9.54%
0%
-9.54%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Mehow Innovative Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.12%
EBIT Growth (5y)
-11.55%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
0.43
Tax Ratio
10.38%
Dividend Payout Ratio
7.95%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.99%
ROE (avg)
10.81%
Valuation key factors
Factor
Value
P/E Ratio
36
Industry P/E
Price to Book Value
2.48
EV to EBIT
28.45
EV to EBITDA
23.93
EV to Capital Employed
3.50
EV to Sales
4.89
PEG Ratio
NA
Dividend Yield
0.13%
ROCE (Latest)
12.31%
ROE (Latest)
6.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
403.10
295.80
36.27%
Operating Profit (PBDIT) excl Other Income
73.40
65.50
12.06%
Interest
0.20
0.00
Exceptional Items
2.40
0.70
242.86%
Consolidate Net Profit
56.70
51.90
9.25%
Operating Profit Margin (Excl OI)
182.10%
133.60%
4.85%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 36.27% vs 5.04% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 9.25% vs -10.52% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,584.10
1,334.20
18.73%
Operating Profit (PBDIT) excl Other Income
441.40
361.30
22.17%
Interest
0.90
1.20
-25.00%
Exceptional Items
0.70
0.00
Consolidate Net Profit
363.80
313.30
16.12%
Operating Profit Margin (Excl OI)
215.60%
201.90%
1.37%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 18.73% vs -5.21% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 16.12% vs -22.08% in Dec 2023
About Mehow Innovative Ltd. 
Mehow Innovative Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






